Dr. Francesco Ceci
nuclear medicine
nuclear medicine
Overview
Country, City
Italy, Milan
Health facility
European Institute of Oncology Milan
Medical unit
Department of nuclear medicine
About the doctor
Skills & Expertise
cancer
prostate
prostate cancer
petct
nuclear medicine
prostatectomy
pet
11ccholine
68gapsma11
radical prostatectomy
hernia
18ffdg
prostatespecific membrane antigen
psa
68gapsma11 petct
radiotherapy
recurrent prostate cancer
18ffdg petct
pelvic
covid19
emission tomography
positron emission tomography
abdominal wall
liver
carcinoma
brain microvessels
lymph node
lung
metastasis
castrationresistant prostate cancer
persistent prostate cancer
fatty liver
tumor
pelvic lymph
pelvic lymph node
abdominal wall repair
neuroendocrine tumor
hormonesensitive prostate cancer
bladder cancer
inguinal hernia
bcell lymphoma
familial hypercholesterolemia
nerve growth
breast cancer
nonalcoholic steatohepatitis
lung nodule
wall reconstruction
renal cell
nodal metastasis
psmapetbased salvage radiotherapy
Resume
CV (Curriculum Vitae)
Education
- 2002-2009 Studied human medicine at the University of Bologna
- Obtaining a license for medical practice
- 2006-2007 Undergraduate Assistant Researcher in nuclear medicine at the University Hospital Rechts der Isar Munich
- 2007 Visiting Undergraduate Fellow in nuclear medicine at the Clinic Grosshadern and Innestadt Clinic of the Ludwig Maximilian University of Munich
- 2007-2009 Undergraduate Assistant Researcher in the nuclear medicine division at the Sant'orsola-Malpighi University Hospital in Bologna
- 2010 Defense of the doctorate: "18F-fluorodeoxyglucose small animal PET study of Sorafenib efficacy in lymphoma preclinical models"
- 2010 Clinical training at the Sant'orsola-Malpighi University Hospital in Bologna
- 2010 Visiting Postgraduate Fellow in the nuclear medicine and clinical physiology unit and hematology unit at the Rigshospitalet of Copenhagen
- 2011-2016 Residency in nuclear medicine at the Sant'orsola-Malpighi University Hospital in Bologna
- 2013 Visiting Researcher in the Department of nuclear medicine at the University Hospital Wuerzburg
- 2014 Visiting Researcher in the Department of nuclear medicine at the Innsbruck University Hospital
- 2016 Obtaining specialization in nuclear medicine
- Dissertation: "68Ga-prostate-specific membrane antigen PET/CT for restaging prostate cancer in patients who experienced biochemical relapse after radical therapy"
- 2016-2020 Ph.D. in surgical sciences at the University of Bologna: "Prediction nomogram for 68Ga-prostate-specific membrane antigen-11 PET/CT in different clinical settings of prostate-specific antigen failure after radical treatment for prostate cancer"
- 2017 Post-doctoral fellowship as a travel grant for a medical researcher at the University of California Los Angeles, promoted by Umberto Veronesi Foundation: "Radiolabeled prostate-specific membrane antigen for diagnosis and treatment of prostate cancer"
- 2017-2018 Visiting Assistant Professor at the Department of molecular and medical pharmacology in nuclear medicine of the University of California Los Angeles
- 2019 Local research at the Department of medical science from the University of Turin: "Application of radiomics analysis applied to 68Ga-DOTA-TOC PET/CT in neuroendocrine tumors"
- 2020 Local research at the Department of medical science from the University of Turin: "18F-fluorodeoxyglucose PET/CT semi-quantitative parameters and multiparametric radiomics signature in patients affected by metastatic melanoma"
Experience
- 2016-2017 PET center of the Department of nuclear medicine at the Sant'orsola-Malpighi University Hospital in Bologna
- 2018-2021 Assistant Professor of the Department of medical sciences at the University of Turin
- 2018-2021 Consultant in nuclear medicine at the University Hospital of Turin
- 2018 Qualified Associate Professor in radiology, nuclear medicine, and radiotherapy
- 2021 Assistant Professor of the Department of oncology and hemato-oncology at the University of Milan
- 2021 Director of the Department of nuclear medicine at the European Institute of Oncology Milan
Awards & Memberships
- 2009 Attended and submitted abstracts to the leading congresses in nuclear medicine and urology from the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, the American Society of Clinical Oncology, the European Association of Urologists, the American Urological Association, and the European Multidisciplinary Congress on Urological Cancers
- 2012-2018 Speaker for the congress from European Association of Nuclear Medicine
- 2014 Speaker for the Society of Nuclear Medicine and Molecular Imaging
- 2015 Associate Editor and Editorial Board Member of the "BioMedical Central Cancer Journal"
- 2016 Rudolf-Hoefer Award for the best Austrian scientific publication on radioactive isotopes in clinical research: "68Ga-prostate-specific membrane antigen PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?"
- 2016 Eckert and Ziegler Abstract Award in abstract competition at the annual congress of the European Association of Nuclear Medicine in Spain: "68Ga-prostate-specific membrane antigen PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and prostate-specific antigen levels < 2 ng/mL"
- 2016 Member of the European Association of Nuclear Medicine
- 2016 Member of the Italian Association of Nuclear Medicine
- 2016 Nominated for the Marie Curie Award among the 20 best abstracts presented at the annual meeting of the European Association of Nuclear Medicine
- 2016 Reviewer for the grant funding on prostate cancer promoted by Kom op Tegen Kanker Foundation in Belgium
- 2017 Faculty Member and Coordinator of the prostate cancer group and thyroid group of the European School of Multimodality Imaging and Therapy
- 2017 Sub-Investigator in nuclear medicine at the Sant'orsola-Malpighi University Hospital in Bologna as the Ricerca Finalizzata national grant founded by the Italian Ministry of Health: "PET/CT imaging for evaluating early response to novel androgen receptor-targeted agents in castration-resistant prostate cancer patients"
- 2017 Nominated for the Marie Curie Award among the 20 best abstracts presented at the Annual meeting of the European Association of Nuclear Medicine
- 2017 Facilitator and Lecturer for the European School of Multimodality Imaging and Therapy of the European Association of Nuclear Medicine
- 2018 Reviewer for register of scientific experts for the Italian Minister of Education, University, and Research, regarding applied research
- 2018 Member of the Italian Society of Uro-Oncology
- 2018-2021 Lecturer of radiology and molecular imaging class and in vivo imaging class at the University of Turin
- 2018-2021 Lecturer of nuclear medicine class at the Radiographer School of the University of Turin
- 2018-2021 Lecturer and Coordinator of the School of Nuclear Medicine in the residency program at the University of Turin
- 2019 Speaker for the Society of Nuclear Medicine and Molecular Imaging
- 2019 Speaker for the European Association of Urologists
- 2019 Speaker for the Society of Nuclear Medicine and Molecular Imaging
- 2019 Co-Principal-Investigator at the Turin Savings Bank Foundation: “Radiomics in neuroendocrine tumors investigated with 68GaDOTA-TOC PET/CT”
- 2019 Facilitator and Lecturer for the Italian Society of Oncological Urology
- 2019 Editorial Board Member of the “Journal of Nuclear Medicine”
- 2020 Nominated for the Marie Curie Award among 3 best abstracts presented at the Annual meeting of the European Association of Nuclear Medicine
- 2020 Speaker for the congress from the European Association of Nuclear Medicine
- 2020 Editorial Board Member of the "European Journal of Nuclear Medicine and Molecular Imaging"
- 2020 Editorial Board Member of the journal "Clinical and Translational Imaging"
- 2020 Faculty Member of the Young Academic Urologists at the European Association of Urology
- 2021 Reviewer for the project from the Dutch Cancer Society: "Application of prostate-specific membrane antigen PET/CT-imaging to personalize treatment in men with biochemically-recurrent prostate cancer previously opting for salvage radiation therapy"
- 2021 Speaker for the section on oncological urology from the European Association of Urologists
- 2021 Lecturer in nuclear medicine and molecular imaging at the Department of oncology and hemato-oncology of the University of Milan
- 2021 Editorial Board Member of the journal "Biomedicines"
- Reviewer for the journal: European Urology, European Urology Oncology, European Urology Focus, Journal of Urology, European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, Oncotarget, Theranostics, Cancers, Biomedicines, European Journal of Nuclear Medicine and Molecular Imaging Research, European Journal of Nuclear Medicine and Molecular Imaging Hybrid, Asia-Pacific Journal of Clinical Oncology, and Biomedical Central Cancer
- Abstract Reviewer for the European Association of Urologists, Society of Nuclear Medicine and Molecular Imaging, and European Association of Nuclear Medicine
- Invited more than 60 times as an honorable speaker to national and international conferences, mainly focusing on PET imaging, theranostics, and prostate cancer, including the Royal Society of Medicine in London
- Guest editor of 1 book edited by Minerva Medica: "Nuclear medicine in the management of prostate cancer"
- Author of 3 book chapters edited by Springer International Publishing
- Authors of more than 100 abstracts presented in international congresses of nuclear medicine, urology, and oncology
Languages
English
Italian
Publications
Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve Patients
1 July, 2024
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models.
20 March, 2024
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial “GIVE ME FIVE”
16 March, 2024
Location
Via Giuseppe Ripamonti, 435, 20141 Milan, Italy
FAQ
Where does the doctor practice?
What is the specialization of Dr. Francesco Ceci?
The primary specialization of the doctor is nuclear medicine.
What is the experience of the specialist?
Dr. Francesco Ceci has been practicing for more than 15 years.
Dr. Francesco Ceci
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Dr. Francesco Ceci